The recombinant zoster vaccine protects adults with HIV against cardiovascular complications such as incident heart failure ...

An infectious disease expert discusses using motivational interviewing and empathetic communication to address vaccine ...

META Older Latino adults show high motivation for RSV vaccination but face significant barriers to actual immunization.

FDA approves Hibsago (bepirovirsen) with NrtI therapy for adult chronic hepatitis B without cirrhosis; phase 3 trials show up to 20% functional cure at 72 weeks.

Treatment-experienced patients with HIV and viremia achieve high virologic suppression with long-acting CAB/RPV.

At IDWeek 2026, Paul Sax, MD, and Cynthia Sears, MD, highlighted practice-changing developments bridging clinical infectious ...

Switching to a once-daily bictegravir/lenacapavir (BIC/LEN) single-tablet regimen is generally well tolerated through 48 ...

The Infectious Disease Advisor team will be covering emerging research and key takeaways from IDWeek 2026, as well as ...

During the 2024-2025 season, influenza vaccination effectively lowered the risk for hospitalization and severe inpatient outcomes among adults.

In people living with HIV and advanced solid tumors who are receiving antiretroviral therapy, treatment with nivolumab plus cabozantinib is safe.

The quadrivalent HPV vaccine provides durable immune responses and protects against cervical disease in women with HIV.

Products that promise relief from genital herpes are easy to order online, but none of them are approved to treat the infection.